| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 34 |
| 1 | SILDENAFIL CITRATE | 19 |
| 2 | MACITENTAN | 14 |
| 3 | FUROSEMIDE | 11 |
| 4 | BOSENTAN | 9 |
| 5 | SPIRONOLACTONE | 9 |
| 6 | TADALAFIL | 8 |
| 7 | AMBRISENTAN | 7 |
| 8 | GABAPENTIN | 7 |
| 9 | ACETAMINOPHEN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 34 | 0.0026 |
| 1 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 2 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 3 | NAFCILLIN SODIUM | 1 | 0.0011 |
| 4 | OXACILLIN SODIUM | 1 | 0.0009 |
| 5 | GANCICLOVIR SODIUM | 5 | 0.0005 |
| 6 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| 7 | DOBUTAMINE | 1 | 0.0003 |
| 8 | LOXAPINE | 1 | 0.0003 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 38 |
| 1 | Endothelin Receptor Antagonist [EPC] | 21 |
| 2 | Loop Diuretic [EPC] | 12 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 11 |
| 4 | Aldosterone Antagonist [EPC] | 10 |
| 5 | Corticosteroid [EPC] | 10 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 7 | Proton Pump Inhibitor [EPC] | 9 |
| 8 | Azole Antifungal [EPC] | 7 |
| 9 | Factor Xa Inhibitor [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 38 | 0.0003 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 4 | 0.0002 |
| 2 | Oxazolidinone Antibacterial [EPC] | 5 | 0.0002 |
| 3 | Penem Antibacterial [EPC] | 5 | 0.0001 |
| 4 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 5 | Endothelin Receptor Antagonist [EPC] | 21 | 0.0001 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 3 | 0.0001 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 11 | 0.0001 |